EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Fibrin clot interference in a human chorionic gonadotrophin assay causing a false Down syndrome screening result

Arzu Etem Akagac, Hatice Bozkurt Yavuz

Biochemia medica · 2023

DOI: 10.11613/bm.2023.011001 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Biochemia medica, 2023. Verfasst von Arzu Etem Akagac und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Training and Research Hospital, Usak University, Usak, Turkey. Hauptthemen laut MEDLINE: Down Syndrome, Thrombosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serum samples are generally used for the measurement of human chorionic gonadotrophin (hCG) to calculate second-trimester maternal screening results. Lower hCG concentrations correlate with a lower calculated risk of Down syndrome (DS). Hence, erroneously low hCG results due to fibrin clot may lead to misinterpretation. We present a 23-year-old woman with a pregnancy of 17+3 weeks. Blood was taken into the Becton-Dickinson (BD) vacutainer SST-II Advance tube (Ref: 367955). The hCG test was performed on Immulite 2000 XPi analyser (Siemens Healthcare Diagnostics Inc, Tarrytown, USA) with original reagents. The results of the same sample were found as 2566 U/L, 18,153 U/L, and 7748 U/L. Three consecutive results after removal of the small fibrin clot and recentrifugation were 18,878, 20,255, and 22,339 U/L. The risk of DS and MoM for the concentration of 2556 U/L hCG was < 1/10,000 and 0.14, respectively. For a hCG concentration of 20,255 U/L, these values were 1/5632 and 1.13, respectively. Laboratory professionals and technicians should be aware that erroneously low hCG results can be measured with the Immulite 2000 XPi due to interference from small fibrin clots. Falsely underestimated hCG values reduce the MoM values and thus the calculated risk of DS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeThrombosisFemaleHumansPregnancyYoung AdultBiomarkersChorionic GonadotropinChorionic Gonadotropin, beta Subunit, HumanPrenatal Diagnosis

Stichwörter der Autor:innen

case reportfibrinhCGpreanalytical phaseprenatal screening

Substanzen

BiomarkersChorionic GonadotropinChorionic Gonadotropin, beta Subunit, Human

Autor:innen und Institutionen

  • Department of Clinical Biochemistry, Training and Research Hospital, Usak University, Usak, Turkey.

Zitieren

APA

Akagac, A. E., & Yavuz, H. B. (2023). Fibrin clot interference in a human chorionic gonadotrophin assay causing a false Down syndrome screening result. Biochemia medica. https://doi.org/10.11613/bm.2023.011001

Vancouver

Akagac AE, Yavuz HB. Fibrin clot interference in a human chorionic gonadotrophin assay causing a false Down syndrome screening result. Biochemia medica. 2023. doi:10.11613/bm.2023.011001

BibTeX
@article{Akagac2023,
  author = {Akagac, Arzu Etem and Yavuz, Hatice Bozkurt},
  title = {Fibrin clot interference in a human chorionic gonadotrophin assay causing a false Down syndrome screening result},
  journal = {Biochemia medica},
  year = {2023},
  doi = {10.11613/bm.2023.011001}
}
Kostenlos starten →